cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2002; 39:393-399
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serruys, P. W.
Right arrow Articles by Colombo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serruys, P. W.
Right arrow Articles by Colombo, A.

A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions

Final results of the additional value of nir stents for treatment of long coronary lesions (ADVANCE) study

Patrick W. Serruys, MD, PhD, FACC, FESC*,*, David P. Foley, MRCPI, PhD, FACC, FESC*, Martin-Jan Suttorp, MD, PhD{dagger}, Benno J. W. M. Rensing, MD, PhD{dagger}, Harry Suryapranata, MD, PhD, FESC{ddagger}, Phillipe Materne, MD§, Arijan van den Bos, MD||, Edouard Benit, MD, FESC, FACC, Angelo Anzuini, MD#, Wolfgang Rutsch, MD, FESC**, Victor Legrand, MD, PhD, FESC{dagger}{dagger}, Keith Dawkins, MD, FRCP{ddagger}{ddagger}, Michael Cobaugh§§, Marco Bressers, MSc||||, Bianca Backx, PhD||||, William Wijns, MD, PhD¶¶ and Antonio Colombo, MD, FACC, FESC#

* Erasmus University, Rotterdam, The Netherlands
{dagger} Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands
{ddagger} Ziekenhuis De Weezenlanden, Zwolle, The Netherlands
§ Hôpital de la Citadelle, Liège, Belgium
|| Medisch Centrum "De Klokkenberg", Breda, The Netherlands
UZ Virga Jesse, Hasselt, Belgium
# Centro Cuore Columbus, Milan, Italy
** Universitätsklinikum Charité, Berlin, Germany
{dagger}{dagger} CHU Sart Tilman, Liège, Belgium
{ddagger}{ddagger} Wessex Cardiology Centre, Southampton, United Kingdom
§§ Boston Scientific GmbH, Ratingen, Germany
|||| Cardialysis, Rotterdam, The Netherlands
¶¶ Onze Lieve Vrouw Ziekenhuis, Aalst, Belgium.



View larger version (19K):

[in a new window]
 
figure 1 Cumulative distribution of minimal lumen diameter (mld) before the procedure (pre), after the procedure (post) and at six-month follow-up (fup) for the balloon angioplasty only group (n = 120; solid line) and the additional stenting group (n = 124; dashed line).

 


View larger version (15K):

[in a new window]
 
Figure 2 Event-free survival during 300 days after the intervention (by the Kaplan-Meier method). Thickest line = additional stenting group (n = 145); medium-thick line = balloon angioplasty only group (n = 143); thin line = bail-out stenting group (n = 149).

 


View larger version (20K):

[in a new window]
 
Figure 3 Logistic regression analysis of lesion length versus major adverse cardiac events (MACE) (top) and restenosis rate (bottom). Both relationships show an advantage of stenting over balloon angioplasty (BA) for shorter lesions; however, in the additional stenting group, there is a significant incremental increase in restenosis and MACE with increased lesion length, a phenomenon that is not seen with BA.

 




 
  cardiology careers collections past issues search home